Low density lipoprotein landmark trials

Jump to: navigation, search

Low Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Physiology

Pathophysiology

Causes

Low LDL
High LDL

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Prognosis and Complications

Diagnosis

Laboratory Findings

Treatment

Medical Therapy

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

Low density lipoprotein landmark trials On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Low density lipoprotein landmark trials

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Low density lipoprotein landmark trials

CDC on Low density lipoprotein landmark trials

Low density lipoprotein landmark trials in the news

Blogs on Low density lipoprotein landmark trials

Directions to Hospitals Treating Low density lipoprotein

Risk calculators and risk factors for Low density lipoprotein landmark trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Landmark Trials

Statin

WOSCOPS Trial (pravastatin)
AFCAPS/TexCAPS Trial (lovastatin)
4S Trial (simvastatin)
Heart Protection Study (simvastatin)
ALLHAT (pravastatin)
PROSPER Trial (pravastatin)
ASCOT-LLA Trial (atorvastatin)
PROVE IT-TIMI 22 Trial (pravastatin or atorvastatin)
ASTEROID Trial (rosuvastatin)
CARDS (atorvastatin)
ASPEN (atorvastatin)
MEGA Trial (pravastatin)
CORONA Trial (rosuvastatin)
JUPITER Trial (rosuvastatin)
SATURN Trial (atorvastatin, rosuvastatin)

Multiple Lipid Lowering Drugs

HARP Study

References


Linked-in.jpg